InvestorsHub Logo
Followers 125
Posts 21010
Boards Moderated 0
Alias Born 06/13/2011

Re: rosemountbomber post# 256

Sunday, 06/09/2024 1:32:10 AM

Sunday, June 09, 2024 1:32:10 AM

Post# of 418
Hi RMB. My wife has some patients on Lanthanum ( those who refuse the main generic ...sorry can't remember name at moment ) and says they are on so many meds already they don't want the anti nausea med . So they either tolerate the Lanthanum or not ....OLC is a derivative of Lanthanum.
These patients are often already on blood pressure meds , statins , blood thinners and a hand full of phosphorous binders .

What was interesting to me is how powerful OLC appears to be ....so maybe some will try lower doses ...just enough to get serum Pho below 6
Also ...70-80% of those needing Pho lowering meds ( total US population of around 400,000) ....could get to Pho goal of 6 .....on OLC ...!!!!
75 % of 400, 000 patients ....300,000 patients in the US
If 2/3 rds can tolerate =200, 000 patients ...reasonable priced to the health provider at $10,000 a yr = $2 B peak US revenue
If half can tolerate / adjust priced at $10,000 a yr = $1B US a year peak rev

So many ways to play with these numbers ....all depends on how many can tolerate / adjust to the drug

Kiwi
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent UNCY News